Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06432543 · ClinicalTrials.gov registry record
Polyethylene Wear Particle Analysis of THA
A clinical trial of Hip Arthropathy and Wear of Articular Bearing Surface of Prosthetic Joint, sponsored by Osaka Metropolitan University.
- Recruiting
- Registry status
- 90
- Enrollment target
- 2
- Study locations
NCT06432543: Recruiting study of Hip Arthropathy and Wear of Articular Bearing Surface of Prosthetic Joint, sponsored by Osaka Metropolitan University.
NCT06432543 is a study of Hip Arthropathy and Wear of Articular Bearing Surface of Prosthetic Joint that is actively recruiting participants, run by Osaka Metropolitan University. The registered enrollment target is 90 participants, above the 41-participant average among 4 other Hip Arthropathy trials with a reported enrollment target (120% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06432543, a study of Hip Arthropathy and Wear of Articular Bearing Surface of Prosthetic Joint, is actively recruiting participants, sponsored by Osaka Metropolitan University.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 2
- Study locations
Study Summary
Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and widely used clinically, but whose mid- to long-term clinical results are still unknown, is superior to conventional polyethylene in vivo. The aim of this project is to conduct an international multi-center joint research study to determine whether polyethylene wear debris production can be reduced in the future, using an in vivo polyethylene wear debris analysis method that the investigators developed as a method that can provide early feedback.
Primary Outcome
counts / g (tissue sample)
Conditions Studied
Interventions
- DEVICE polyethylene
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
Other
- Osaka Metropolitan University - Osaka
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2028-12-31 |
What NCT06432543 shows while recruiting
NCT06432543 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, above the 41-participant average among 4 other Hip Arthropathy trials with a reported enrollment target (120% higher).
The record links to 2 conditions, with Hip Arthropathy appearing as the primary indexed condition, and to 1 intervention - of which polyethylene is the first listed.
NCT06432543 reports a single indexed study location in Minnesota, Other.
Frequently Asked Questions
What is clinical trial NCT06432543 about?
NCT06432543 is a clinical study titled "Polyethylene Wear Particle Analysis of THA". Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and widely used clinically, but whose mid- to long-term clinical results are still unknown, is superior...
What is the current status of trial NCT06432543?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2024-06-01. Estimated completion is 2028-12-31.
What conditions does trial NCT06432543 study?
This clinical trial studies the following conditions: Hip Arthropathy, Wear of Articular Bearing Surface of Prosthetic Joint.
What interventions are being tested in trial NCT06432543?
The interventions under investigation include: polyethylene (DEVICE).
Who is sponsoring clinical trial NCT06432543?
This trial is sponsored by Osaka Metropolitan University, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06432543 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Arthropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI